# 바이오스페이스 일일 뉴스 리포트 - 2025년 08월 27일


## 주요 헤드라인

1. **Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-plots-path-to-fda-after-second-phase-iii-readout-for-orforglipron>

2. **Lilly Plots Path to FDA After Second Phase III Readout for Orforglipron (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/lilly-plots-path-to-fda-after-second-phase-iii-readout-for-orforglipron>

3. **CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/cdc-names-vaccine-critic-retsef-levi-as-head-of-covid-19-workgroup>

4. **CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/cdc-names-vaccine-critic-retsef-levi-as-head-of-covid-19-workgroup>

5. **Argenx Eyes ‘Broadest Label’ for Vyvgart in Myasthenia Gravis After Positive Phase III Data (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/argenx-eyes-broadest-label-for-vyvgart-in-myasthenia-gravis-after-positive-phase-iii-data>

6. **Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’ (#뉴스)**
   - Article content not available
   <https://www.biospace.com/policy/trump-kennedy-could-ban-covid-19-vaccine-within-months-report>

7. **Appia, Former Kite Cell Therapy Collaborator, Shuts Down (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/kite-cell-therapy-collaborator-appia-shutters>


---
*2025년 08월 27일 바이오스페이스 뉴스 피드에서 생성된 리포트*